Trial Profile
A Double-blind, Placebo-controlled Pilot Study to Collect and Evaluate Data on the Use of Intravenous Ibuprofen in the Treatment of an Acute Migraine Attack
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Sep 2022
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Acronyms intravenous
- 16 Aug 2022 Status changed from discontinued to completed.
- 03 Oct 2021 Status changed to discontinued , according to Results published in the Headache
- 03 Oct 2021 Primary endpoint has not been met (Comparison of proportion of subjects in control and active treatment groups who have pain relief at 2 hours after the completion of the double-blind treatment infusion) , according to Results published in the Headache